NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Biotechnology · USD

Whitehawk Therapeutics, Inc. (WHWK) Stock Analysis

Whitehawk Therapeutics, Inc. (WHWK) is a Biotechnology stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

WHWK

$3.29

+$0.10 (+2.98%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare WHWK with… →

WHWK Key Statistics

As of Oct 21, 2026
Trading
Open
$3.20
Previous Close
$3.19
Day's Range
3.13–3.32
52-Week Range
1.97–5.50
Volume
279.99K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.91
Valuation
Market Cap
$187.27M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.14
Financials (FY)
Revenue (FY)
$7.15M−72.50%
Net Income (FY)
−$20.60M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
57.01M
1-Year Return
+44.08%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
371.22K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, WHWK closed at $3.29, +44.08% over 1 year.

Whitehawk Therapeutics, Inc. (WHWK) has a market capitalization of $187.27M.

In fiscal 2025, WHWK reported revenue of $7.15M.

WHWK Stock Return by Calendar Year

Whitehawk Therapeutics, Inc. (WHWK) return since Feb 2018: what $10,000 became

1 year
$10,000 $14,408
+44.08%
5 years
$10,000 $1,223
−87.77%
Since Feb 2018
$10,000 $487
−95.13%

If you had invested $10,000 in Whitehawk Therapeutics, Inc. (WHWK) at the close on February 16, 2018, the earliest close on record here, it would have been worth $487 at the close on October 21, 2026: −95.13% in total, −29.42% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+35.74%
2025−23.30%
2024+56.19%
2023−84.26%
2022−46.87%
2021+64.29%
2020+57.05%
2019−63.29%
2018 (partial year)−62.22%

As of October 21, 2026.

WHWK Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$7.15M−$20.60M−288.3%
2024$25.98M−$63.69M−245.1%
2023$24.35M−$65.77M−270.0%
2022$15.22M−$60.51M−397.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$7.15M$6.39M−$114.40M−$20.60M−288.3%
2024$25.98M$22.96M−$64.82M−$63.69M−245.1%
2023$24.35M$21.55M−$71.93M−$65.77M−270.0%
2022$15.22M$13.88M−$58.96M−$60.51M−397.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

Recent News

All 9 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Whitehawk Therapeutics, Inc. (WHWK) carries a market capitalisation of $187.27M. The company sits in the Healthcare sector, in the Biotechnology industry. Headcount on file is 32.

The most recent close on file for WHWK is $3.29, dated October 21, 2026. That is +$0.10 (+2.98%) against the previous close. The 52-week range on file runs from $1.97 to $5.50. The latest close sits 66.75% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $7.15M. That is −72.50% against the prior fiscal year, when revenue was $25.98M. The same year closed with a net loss of $20.60M. Trailing earnings per share are −1.14.

Across the 4 fiscal years on file, revenue moves from $15.22M in 2022 to $7.15M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative.

Beta against the wider market is reported at 0.91. Daily returns over the trailing 8 years annualize to a volatility of 87.26%. Over the trailing twelve months the total return is +44.08%. Measured over 5 years, that is −34.31% a year compounded.

Growth & Income

No dividend is on file for WHWK.

So far in 2026 the total return is +35.74%. Across the complete calendar years on file, 2021 returned +64.29% and 2023 returned −84.26%. Of the 7 complete calendar years on file, 3 finished higher.

Peer Comparison

Whitehawk Therapeutics, Inc. (WHWK) operates in the Biotechnology industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Whitehawk Therapeutics, Inc. WHWK $187.27M —
Vertex Pharmaceuticals Incorporated VRTX $132.95B 30.4
Moderna, Inc. MRNA $98.14B —
Regeneron Pharmaceuticals, Inc. REGN $82.95B 19.9

The Biotechnology industry average P/E ratio is 16.6x. Whitehawk Therapeutics, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Biotechnology Stocks

VRTX

Vertex Pharmaceuticals Incorporated

$132.95B

 MRNA

Moderna, Inc.

$98.14B

 REGN

Regeneron Pharmaceuticals, Inc.

$82.95B

 ARGX

argenx SE

$55.97B

 ONC

BeOne Medicines AG

$43.97B

 RVMD

Revolution Medicines, Inc.

$41.64B
View all Biotechnology stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Visit website →